Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-14-022494

Director sold 20,000 shares at $4.54 ($90,800)

  • Director acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lawrence Thomas R Director 2014-03-21 Grant or award +1,000 $4.58 $4,580 100,381 D
Lawrence Thomas R Director 2014-03-19 Sale −20,000 $4.54 $90,800 80,381 D
Open-market sales · 20,000 sh · avg $4.54 · $90,800
Loading xslF345X03/doc4.xml…